We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$406M
AUM Growth
-$32.3M
Cap. Flow
-$132M
Cap. Flow %
-32.56%
Top 10 Hldgs %
49.27%
Holding
151
New
39
Increased
19
Reduced
25
Closed
51

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$31.3M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$19.6M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.25M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$6.43M
5
AGN
Allergan Inc
AGN
+$6.23M

Top Sells

Rank Stock Value
1
SMMF
Summit Financial Group, Inc.
SMMF
+$116M
2
GSK icon
GSK
GSK
+$19M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$15.2M
4
LLY icon
Eli Lilly
LLY
+$11.9M
5
SNY icon
Sanofi
SNY
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 73.98%
2 Technology 4.07%
3 Consumer Discretionary 3.5%
4 Industrials 2.92%
5 Communication Services 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMBI
51
DELISTED
Ambit Biosciences Corp
AMBI
$1.92M 0.47%
277,568
+129,100
+87% +$905K
VRTX icon
52
CALL
Vertex Pharmaceuticals
VRTX
$121B
$1.91M 0.47%
1,000
+500
+100% +$35.1K
RXDX
53
DELISTED
Ignyta, Inc.
RXDX
$1.86M 0.46%
205,000
– –
XLV icon
54
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$1.79M 0.44%
29,353
-130,000
-82% -$7.64M
NGNE icon
55
Neurogene
NGNE
$656M
$1.78M 0.44%
9,500
– –
OMED
56
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.75M 0.43%
+75,000
New +$1.85M
CYTR
57
DELISTED
CytRx Corp
CYTR
$1.67M 0.41%
66,667
-833
-1% -$19K
GLMD icon
58
Galmed Pharmaceuticals
GLMD
$5.13M
$1.66M 0.41%
944
– –
PBYI icon
59
Puma Biotechnology
PBYI
$404M
$1.65M 0.41%
+25,000
New +$1.78M
NPSP
60
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.62M 0.4%
49,000
-29,000
-37% -$838K
ITCI
61
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.59M 0.39%
94,300
-5,700
-6% -$94.2K
INSM icon
62
Insmed
INSM
$21.4B
$1.59M 0.39%
79,400
+9,400
+13% +$139K
RNA
63
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$1.58M 0.39%
+125,000
New +$1.01M
GNVC
64
DELISTED
GenVec, Inc.
GNVC
$1.48M 0.36%
57,500
– –
CVS icon
65
CVS Health
CVS
$133B
$1.45M 0.36%
19,295
-16,500
-46% -$1.25M
PAG icon
66
Penske Automotive Group
PAG
$14.3B
$1.45M 0.36%
+29,327
New +$1.34M
ARWR icon
67
Arrowhead Research
ARWR
$11.9B
$1.43M 0.35%
+100,000
New +$1.31M
TJX icon
68
TJX Companies
TJX
$174B
$1.38M 0.34%
51,832
-98,000
-65% -$2.8M
SAH icon
69
Sonic Automotive
SAH
$2.9B
$1.33M 0.33%
+50,000
New +$1.25M
ARRY
70
DELISTED
Array Biopharma Inc
ARRY
$1.3M 0.32%
+285,000
New +$1.18M
BLRX
71
BioLineRX
BLRX
$12.3M
$1.25M 0.31%
1,000
– –
TEVA icon
72
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$1.24M 0.31%
3,210
+210
+7% +$10.7K
TLOG
73
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$1.18M 0.29%
200,000
– –
AGIO icon
74
Agios Pharmaceuticals
AGIO
$1.79B
$1.15M 0.28%
+25,000
New +$1.02M
ACHN
75
DELISTED
Achillion Pharmaceuticals
ACHN
$1.14M 0.28%
+150,000
New +$599K
1 2
3
4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2014 Portfolio in Review

As of Q2 2014, Sphera Funds Management held 151 positions worth $406M, down 7.4% from $438M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sphera Funds Management withdrew a net $132M in Q2 2014, closing 51 positions and reducing 25 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Sphera Funds Management opened a new position in Shire pic worth $14.1M.

  • Sphera Funds Management's largest Q2 2014 buy was Shire pic: 180,000 shares worth $14.1M.
  • Sphera Funds Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $19.6M increase.
  • Sphera Funds Management's biggest Q2 2014 reduction was Summit Financial Group, Inc., cutting an estimated $116M.
  • Sphera Funds Management fully exited State Street Financial Select Sector SPDR ETF in Q2 2014, selling an estimated $15.2M.
  • Sphera Funds Management's ten largest holdings make up 49% of its $406M portfolio in Q2 2014.
  • Sphera Funds Management opened 39 new positions and closed 51 in Q2 2014.
  • Sphera Funds Management's portfolio value fell 7.4% quarter-over-quarter to $406M.

Based on Sphera Funds Management's 13F filing for Q2 2014, filed 11 Aug 2014.